Skip to main content
. Author manuscript; available in PMC: 2019 Feb 3.
Published in final edited form as: J Pain Symptom Manage. 2018 Mar 8;56(1):44–52. doi: 10.1016/j.jpainsymman.2018.03.001

Table 1.

Demographic and Medical Characteristics of the Sample (N = 120)

Participant Characteristic n (%)
Age, yrs (mean [SD]; range) 56.0 (8.7) 27.0−76.0
Gender
 Male 73 (60.8)
 Female 47 (39.2)
Race/Ethnicity
 White 91 (75.8)
 Black 12 (10.0)
 Hispanic 11 (9.2)
 American Indian/Alaskan Native 1 (0.8)
 Other 3 (2.5)
Marital status
 Married or cohabiting 61 (50.8)
 Separated 4 (3.3)
 Divorced 29 (24.2)
 Widowed 5 (4.2)
 Single 19 (15.8)
Occupational status
 Full-time 20 (16.7)
 Part-time 5 (4.2)
 Unemployed 34 (28.3)
 Disability 59 (49.2)
Incomea
 <5000 6 (5.0)
 5000–19,999 26 (21.7)
 20,000–34,999 19 (15.8)
 35,000–49,999 12 (10.0)
 50,000–64,999 8 (6.7)
 65,000–89,999 10 (8.3)
 90,000–119,999 13 (10.8)
 120,000 or more 5 (4.2)
Liver disease etiologyb
 HCV 62 (51.7)
 ALD 18 (15.0)
 HCC alone 2 (1.7)
 NASH 11 (9.2)
 Otherc 26 (21.7)
HCC status
 Yes 30 (25.0)
 No 89 (74.2)
Disease severity
 MELD 12.50 (4.5) 6.0–26.0
 Karnofsky 85.0 (9.0) 40.0–100.0
Current psychiatric diagnosis (n = 39)d
 Anxiety disorder 5 (12.8)
 Depressive disorder 10 (25.6)
 Adjustment disorder 6 (15.4)
 Binge eating disorder 1 (2.6)
 No diagnosis 19 (48.7)
 Not assessed/incomplete 81
Past psychiatric diagnosis
 Alcohol use disorder 20 (51.3)
 Cocaine dependence 2 (5.1)
 Depressive disorder 7 (17.9)
 Heroin dependence 2 (5.1)
 Marijuana abuse 2 (5.1)
 Opioid dependence 2 (5.1)
 Panic disorder 1 (2.6)
 Polysubstance dependence 5 (5.1)
 No diagnosis 7 (17.9)
 Not assessed/incomplete  81

HCV = hepatitis C virus; ALD = alcoholic liver disease; HCC = hepatocellular carcinoma; NASH = nonalcoholic steatohepatitis; MELD = Model for End-Stage Liver Disease; SCID = Structured Clinical Interview for DSM-IV Axis I Disorders.

a

Income in U.S. dollars.

b

These data were collected between 2008 and 2011; subsequently there has been a national decline in the number of waitlisted patients with HCV because of the introduction of antiviral agents in late 2014.4

c

Other diagnoses include genetic, metabolic, autoimmune, and unknown etiologies of liver disease.

d

The SCID was removed from the study protocol because of time and resource limitations. Two patients met criteria for two current DSM-IV diagnoses.